Literature DB >> 7573424

Role of glucagon in maintenance of euglycemia in fed and fasted rats.

C L Brand1, P N Jørgensen, U Knigge, J Warberg, I Svendsen, J S Kristensen, J J Holst.   

Abstract

The role of glucagon in the regulation of blood glucose in fed and fasted anesthetized rats was studied by injecting intravenously 4 ml/kg of a high-capacity (40 nmol/ml) high-affinity (0.6 x 10(11) mol/l) monoclonal glucagon antibody. Blood glucose was lowered by the antibody by 2 mmol/l in fed rats but remained unchanged in 10- and 48-h-fasted rats. Antibody injection significantly reduced plasma insulin in both fed and 10-h-fasted rats. In 10-h-fasted rats, propranolol injection decreased blood glucose by 0.6 mmol/l, and combined with antibody administration, a decrease by 1.1 mmol/l was observed. Blood glucose was never < 3.3 mmol/l. Thus glucagon is partly responsible for maintenance of euglycemia in fed rats, whereas during fasting it plays a limited role. However, immunoneutralization of glucagon reduces insulin secretion irrespective of blood glucose. Additional mechanisms seem to be responsible for the maintenance of blood glucose in the fasting state when glucagon and the sympathoadrenergic system are blocked.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7573424     DOI: 10.1152/ajpendo.1995.269.3.E469

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  31 in total

1.  The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas.

Authors:  J de Heer; J Pedersen; C Orskov; J J Holst
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

2.  Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies?

Authors:  Jens Juul Holst
Journal:  Diabetologia       Date:  2013-07-03       Impact factor: 10.122

3.  Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice.

Authors:  Aidan S Hancock; Aiping Du; Jingxuan Liu; Mayumi Miller; Catherine L May
Journal:  Mol Endocrinol       Date:  2010-06-30

4.  Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs.

Authors:  Christopher J Ramnanan; Viswanathan Saraswathi; Marta S Smith; E Patrick Donahue; Ben Farmer; Tiffany D Farmer; Doss Neal; Philip E Williams; Margaret Lautz; Andrea Mari; Alan D Cherrington; Dale S Edgerton
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

5.  ADAM 12 protease induces adipogenesis in transgenic mice.

Authors:  Nobuko Kawaguchi; Xiufeng Xu; Rie Tajima; Pauliina Kronqvist; Christina Sundberg; Frosty Loechel; Reidar Albrechtsen; Ulla M Wewer
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

6.  Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice.

Authors:  J Mu; G Jiang; E Brady; Q Dallas-Yang; F Liu; J Woods; E Zycband; M Wright; Z Li; K Lu; L Zhu; X Shen; R Sinharoy; M L Candelore; S A Qureshi; D-M Shen; F Zhang; E R Parmee; B B Zhang
Journal:  Diabetologia       Date:  2011-06-22       Impact factor: 10.122

7.  Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.

Authors:  S L Conarello; G Jiang; J Mu; Z Li; J Woods; E Zycband; J Ronan; F Liu; R Sinha Roy; L Zhu; M J Charron; B B Zhang
Journal:  Diabetologia       Date:  2006-11-28       Impact factor: 10.122

8.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

9.  cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis.

Authors:  Derek M Erion; Maya E Kotas; Jacob McGlashon; Shin Yonemitsu; Jennifer J Hsiao; Yoshio Nagai; Takanori Iwasaki; Susan F Murray; Sanjay Bhanot; Gary W Cline; Varman T Samuel; Gerald I Shulman; Matthew P Gillum
Journal:  J Biol Chem       Date:  2013-04-17       Impact factor: 5.157

10.  Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.

Authors:  J de Heer; C Rasmussen; D H Coy; J J Holst
Journal:  Diabetologia       Date:  2008-09-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.